Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
81-100 of 262 ARTICLES
https://doi.org/10.12688/f1000research.131013.2
Research Article metrics
Revised
Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach
[version 2; peer review: 3 approved]
Peer Reviewers Dicson Sheeja Malar; Gurudeeban Selvaraj; Rajasekaran R.
  • Funder
  • This work was primarily supported by grants from the Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
LATEST VERSION PUBLISHED 18 Jun 2024
https://doi.org/10.12688/f1000research.136087.2
Brief Report metrics
Revised
Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition
[version 2; peer review: 2 approved]
Peer Reviewers Konstantinos Kamposioras; Athanasia Pavlopoulou
  • Funder
  • European Union and Greek national funds, Operational Program Competitiveness, Entrepreneurship and Innovation, under RESEARCH—CREATE—INNOVATE
LATEST VERSION PUBLISHED 14 Jun 2024
https://doi.org/10.12688/f1000research.133862.2
Research Article metrics
Revised
Prognostic role of tumor budding in oral squamous cell carcinoma: a retrospective study
[version 2; peer review: 1 approved]
Peer Reviewers Devendra Palve
LATEST VERSION PUBLISHED 12 Jun 2024
https://doi.org/10.12688/f1000research.138780.2
Case Report metrics
Revised
Case Report: Sebaceous carcinoma of the eyelid
[version 2; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Jianmin Ma; Vijitha S Vempuluru
LATEST VERSION PUBLISHED 12 Jun 2024
https://doi.org/10.12688/f1000research.134992.3
Systematic Review metrics
Revised
Association between eNOS rs1799983 (894G>T) Polymorphism with Cancer and Stroke Risk: A meta-analysis
[version 3; peer review: 1 approved with reservations, 3 not approved]
Peer Reviewers Eric Tzyy Jiann Chong; Katrina Miranda; Mirza Saqib Baig; Saori Furuta
  • Funder
  • Lembaga Penelitian dan Inovasi Universitas Airlangga
LATEST VERSION PUBLISHED 10 Jun 2024
https://doi.org/10.12688/f1000research.134757.2
Study Protocol metrics
Revised
Protocol for correlation of histological risk assessment/scoring system with a depth of invasion in oral squamous cell carcinoma
[version 2; peer review: 2 approved]
Peer Reviewers Alessandro Polizzi; Jose A. Hardillo
LATEST VERSION PUBLISHED 31 May 2024
https://doi.org/10.12688/f1000research.127691.2
Research Article metrics
Revised
Breast cancer related physical, psychological, social and spiritual domains of quality of life among women in Bahrain
[version 2; peer review: 1 approved, 2 not approved]
Peer Reviewers Salwa Hagag Abdelaziz; Chung-Ying Lin; Tharin Phenwan
LATEST VERSION PUBLISHED 28 May 2024
https://doi.org/10.12688/f1000research.132627.3
Research Article metrics
Revised
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Peer Reviewers Griffith D Parks; Estanislao Nistal-Villan and Vicent Tur-Planells; Thomas C. N. Leung; Monica Martinez Pacheco
  • Funders
  • Rosetrees Trust
  • Neuroblastoma UK
  • Medical Research Council
  • Children's Cancer and Leukaemia Group
  • Wessex Medical Research
LATEST VERSION PUBLISHED 21 May 2024
https://doi.org/10.12688/f1000research.148984.1
Case Report metrics
Case Report: Urothelial urethral carcinoma in HIV patient underwent total urethrectomy and perineal urethrostomy
[version 1; peer review: 1 approved]
Peer Reviewers Pande Made Wisnu Tirtayasa
PUBLISHED 08 May 2024
https://doi.org/10.12688/f1000research.145493.2
Review metrics
Revised
Hepatocellular carcinoma: Advances in systemic therapies
[version 2; peer review: 3 approved]
Peer Reviewers Won-Mook Choi; Shang-Chin Huang; Leonardo Stella
LATEST VERSION PUBLISHED 07 May 2024
https://doi.org/10.12688/f1000research.148756.1
Research Article metrics
CD24 and Oct4: Cancer stem markers expression correlates with histological subtyping of head and neck squamous cell carcinoma
[version 1; peer review: 1 approved with reservations]
Peer Reviewers V K Varsha
  • Funder
  • University of Health Sciences Lahore
PUBLISHED 23 Apr 2024
https://doi.org/10.12688/f1000research.146356.1
Research Article metrics
Impact of CYP3A4 rs2242480 polymorphisms on Imatinib HPLC determined trough concentration and response in Chronic Myeloid Leukaemia in Pakistani patients
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Aijun Zhang; Nicholas Cross
PUBLISHED 22 Apr 2024
https://doi.org/10.12688/f1000research.126721.2
Research Article metrics
Revised
Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Mattia Lauriola; Ritu Pandey and Daruka Mahadevan; Akila Prashant and Deepthi V
LATEST VERSION PUBLISHED 04 Apr 2024
https://doi.org/10.12688/f1000research.134826.3
Case Report metrics
Revised
Case Report: Basaloid Squamous Cell Carcinoma of the Tongue
[version 3; peer review: 2 approved, 2 approved with reservations]
Peer Reviewers Muhammad Kashif; Abikshyeet Panda; Namrata Patil; Neetu Jain and Shashi Keshwar
LATEST VERSION PUBLISHED 26 Mar 2024
https://doi.org/10.12688/f1000research.146052.2
Research Article metrics
Revised
Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study
[version 2; peer review: 2 approved]
Peer Reviewers Avantsa Rohini; Mubarak Taiwo Mustapha
LATEST VERSION PUBLISHED 14 Mar 2024
https://doi.org/10.12688/f1000research.135809.2
Method Article metrics
Revised
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
[version 2; peer review: 2 approved]
Peer Reviewers Natividad Gomez-Roman; Anke Brüning-Richardson
  • Funders
  • Urology Foundation
  • Brain Tumour Charity
  • Weston Park Cancer Charity
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 11 Mar 2024
https://doi.org/10.12688/f1000research.133064.1
Clinical Practice Article metrics AWAITING PEER REVIEW
Managing recurrent/advanced oropharyngeal/oesophageal cancer with cetuximab-based regimens: A case series
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • None
PUBLISHED 22 Feb 2024
https://doi.org/10.12688/f1000research.142460.1
Research Article metrics AWAITING PEER REVIEW
The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • This work was supported by Pfizer Pharmaceutical Company.
PUBLISHED 18 Jan 2024
https://doi.org/10.12688/f1000research.131810.2
Method Article metrics
Revised
Development of an in vitro microfluidic model to study the role of microenvironmental cells in oral cancer metastasis
[version 2; peer review: 2 approved]
Peer Reviewers Vivek Thacker; Christopher Jon Hanley
  • Funder
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 15 Jan 2024
https://doi.org/10.12688/f1000research.128907.1
Case Report metrics AWAITING PEER REVIEW
Case Report: Primary follicular lymphoma of the colon presenting as an incidental finding on endoscopy
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 12 Jan 2024
81-100 of 262 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.